IDEXX LABORATORIES INC /DE Proceeds from (Repayments of) Other Debt
IDEXX LABORATORIES INC /DE (IDXX) reported Proceeds from (Repayments of) Other Debt of $198.11 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-04-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherDebt · last filed 2020-04-30
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for the quarter ending 2020-03-31 was $198.11M.
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for the quarter ending 2019-12-31 was $59.26M.
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for the quarter ending 2019-09-30 was -$22.01M.
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for the quarter ending 2019-06-30 was -$95.50M, a 423.71% decline year-over-year.
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for fiscal 2019 was -$110.28M.
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for fiscal 2018 was -$256.04M, a 681.91% decline from fiscal 2017.
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for fiscal 2017 was $44.00M, a 15.79% increase from fiscal 2016.
- IDEXX LABORATORIES INC /DE proceeds from (repayments of) other debt for fiscal 2016 was $38.00M, a 58.33% increase from fiscal 2015.
| Period end | Proceeds from (Repayments of) Other Debt 3 month | Proceeds from (Repayments of) Other Debt 6 month | Proceeds from (Repayments of) Other Debt 9 month | Proceeds from (Repayments of) Other Debt 12 month |
|---|---|---|---|---|
| 2020-03-31 | $198.11M 10-Q · filed 2020-04-30 | $257.37M derived: sum of 2 quarters · filed 2020-04-30 | $235.35M derived: sum of 3 quarters · filed 2020-04-30 | $139.86M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | $59.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $37.24M derived: sum of 2 quarters · filed 2020-02-14 | -$58.25M derived: sum of 3 quarters · filed 2020-02-14 | -$110.28M 10-K · filed 2020-02-14 |
| 2019-09-30 | -$22.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$117.51M derived: sum of 2 quarters · filed 2019-10-31 | -$169.53M 10-Q · filed 2019-10-31 | -$185.07M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-06-30 | -$95.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$147.52M 10-Q · filed 2019-08-01 | -$163.06M derived: sum of 3 quarters · filed 2020-04-30 | -$185.56M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-03-31 | -$52.02M 10-Q · filed 2020-04-30 | -$67.56M derived: sum of 2 quarters · filed 2020-04-30 | -$90.06M derived: sum of 3 quarters · filed 2020-04-30 | -$60.56M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | -$15.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$38.04M derived: sum of 2 quarters · filed 2020-02-14 | -$8.54M derived: sum of 3 quarters · filed 2020-02-14 | -$256.04M 10-K · filed 2020-02-14 |
| 2018-09-30 | -$22.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $7.00M derived: sum of 2 quarters · filed 2019-10-31 | -$240.50M 10-Q · filed 2019-10-31 | -$271.75M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $29.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$218.00M 10-Q · filed 2019-08-01 | -$249.25M derived: sum of 3 quarters · filed 2020-02-14 | -$267.00M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | -$247.50M 10-Q · filed 2019-05-01 | -$278.75M derived: sum of 2 quarters · filed 2020-02-14 | -$296.50M derived: sum of 3 quarters · filed 2020-02-14 | -$263.50M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | -$31.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$49.00M derived: sum of 2 quarters · filed 2020-02-14 | -$16.00M derived: sum of 3 quarters · filed 2020-02-14 | $44.00M 10-K · filed 2020-02-14 |
| 2017-09-30 | -$17.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $15.25M derived: sum of 2 quarters · filed 2018-11-01 | $75.25M 10-Q · filed 2018-11-01 | $198.25M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $93.00M 10-Q · filed 2018-08-01 | $216.00M derived: sum of 3 quarters · filed 2019-02-15 | $146.00M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $60.00M 10-Q · filed 2018-05-04 | $183.00M derived: sum of 2 quarters · filed 2019-02-15 | $113.00M derived: sum of 3 quarters · filed 2019-02-15 | $49.00M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $123.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $53.00M derived: sum of 2 quarters · filed 2019-02-15 | -$11.00M derived: sum of 3 quarters · filed 2019-02-15 | $38.00M 10-K · filed 2019-02-15 |
| 2016-09-30 | -$70.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$134.00M derived: sum of 2 quarters · filed 2017-10-31 | -$85.00M 10-Q · filed 2017-10-31 | -$54.50M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | -$64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$15.00M 10-Q · filed 2017-08-01 | $15.50M derived: sum of 3 quarters · filed 2018-02-16 | $60.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $49.00M 10-Q · filed 2017-04-28 | $79.50M derived: sum of 2 quarters · filed 2018-02-16 | $124.00M derived: sum of 3 quarters · filed 2018-02-16 | $72.50M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $30.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $75.00M derived: sum of 2 quarters · filed 2018-02-16 | $23.50M derived: sum of 3 quarters · filed 2018-02-16 | $24.00M 10-K · filed 2018-02-16 |
| 2015-09-30 | $44.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$7.00M derived: sum of 2 quarters · filed 2016-11-01 | -$6.50M 10-Q · filed 2016-11-01 | $167.50M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$51.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$51.00M 10-Q · filed 2016-08-02 | $123.00M derived: sum of 3 quarters · filed 2017-02-17 | $114.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $500.00K 10-Q · filed 2016-04-29 | $174.50M derived: sum of 2 quarters · filed 2017-02-17 | $165.50M derived: sum of 3 quarters · filed 2017-02-17 | $234.50M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $174.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $165.00M derived: sum of 2 quarters · filed 2017-02-17 | $234.00M derived: sum of 3 quarters · filed 2017-02-17 | $272.00M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $60.00M derived: sum of 2 quarters · filed 2015-10-28 | $98.00M 10-Q · filed 2015-10-28 | -$22.20M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $69.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $107.00M 10-Q · filed 2015-07-30 | -$13.20M derived: sum of 3 quarters · filed 2016-02-17 | $16.50M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $38.00M 10-Q · filed 2015-04-28 | -$82.20M derived: sum of 2 quarters · filed 2016-02-17 | -$52.50M derived: sum of 3 quarters · filed 2016-02-17 | $55.00M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | -$120.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | -$90.50M derived: sum of 2 quarters · filed 2016-02-17 | $17.00M derived: sum of 3 quarters · filed 2016-02-17 | $65.00M 10-K · filed 2016-02-17 |
| 2013-09-30 | $29.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $137.20M derived: sum of 2 quarters · filed 2014-10-24 | $185.20M 10-Q · filed 2014-10-24 | $165.20M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $107.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $155.50M 10-Q · filed 2014-07-25 | $135.50M derived: sum of 3 quarters · filed 2015-02-17 | $123.50M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $48.00M 10-Q · filed 2014-04-25 | $28.00M derived: sum of 2 quarters · filed 2015-02-17 | $16.00M derived: sum of 3 quarters · filed 2015-02-17 | $6.00M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$32.00M derived: sum of 2 quarters · filed 2015-02-17 | -$42.00M derived: sum of 3 quarters · filed 2015-02-17 | -$31.00M 10-K · filed 2015-02-17 |
| 2012-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | -$22.00M derived: sum of 2 quarters · filed 2013-10-22 | -$11.00M 10-Q · filed 2013-10-22 | $78.00M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $1.00M 10-Q · filed 2013-07-23 | $90.00M derived: sum of 3 quarters · filed 2014-02-18 | $111.42M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $11.00M 10-Q · filed 2013-04-23 | $100.00M derived: sum of 2 quarters · filed 2014-02-18 | $121.42M derived: sum of 3 quarters · filed 2014-02-18 | $127.39M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $110.42M derived: sum of 2 quarters · filed 2014-02-18 | $116.39M derived: sum of 3 quarters · filed 2014-02-18 | $113.90M 10-K · filed 2014-02-18 |
| 2011-09-30 | $21.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | $27.39M derived: sum of 2 quarters · filed 2012-10-19 | $24.90M 10-Q · filed 2012-10-19 | $27.91M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $5.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | $3.49M 10-Q · filed 2012-07-20 | $6.49M derived: sum of 3 quarters · filed 2013-02-19 | -$1.47M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | -$2.49M 10-Q · filed 2012-04-20 | $521.00K derived: sum of 2 quarters · filed 2013-02-19 | -$7.44M derived: sum of 3 quarters · filed 2013-02-19 | -$30.87M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$4.96M derived: sum of 2 quarters · filed 2013-02-19 | -$28.38M derived: sum of 3 quarters · filed 2013-02-19 | $10.14M 10-K · filed 2013-02-19 |
| 2010-09-30 | -$7.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | -$31.39M derived: sum of 2 quarters · filed 2011-10-21 | $7.13M 10-Q · filed 2011-10-21 | -$16.90M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | -$23.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | $15.10M 10-Q · filed 2011-07-22 | -$8.93M derived: sum of 3 quarters · filed 2012-02-17 | -$21.51M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $38.52M 10-Q · filed 2011-04-21 | $14.49M derived: sum of 2 quarters · filed 2012-02-17 | $1.91M derived: sum of 3 quarters · filed 2012-02-17 | |
| 2009-12-31 | -$24.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | -$36.61M derived: sum of 2 quarters · filed 2012-02-17 | -$32.83M 10-K · filed 2012-02-17 | |
| 2009-09-30 | -$12.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | -$8.80M 10-Q · filed 2010-10-22 | ||
| 2009-06-30 | $3.78M 10-Q · filed 2010-07-23 | |||
| 2008-12-31 | $79.55M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |